▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Neurocrine Biosciences To Present At Morgan Stanley Healthcare Conference; Webcast At 10:15 AM ET

By RTTNews Staff Writer ✉ | Published: 9/13/2021 9:15 AM ET

Neurocrine Biosciences Inc. (NBIX) will present at the Morgan Stanley 19th Annual Healthcare Conference.

The event is scheduled to begin at 10:15 AM ET on September 13, 2021.

To access the live webcast, log on to http://www.neurocrine.com

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

U.S. Covid Cases Fall 18% In A Fortnight

U.S. Reports 128K New Covid Cases, 464 Deaths

Roche Unveils Elecsys IGRA SARS-CoV-2 Test In Countries That Accept CE Mark

CDC No Longer Recommends Quarantine, Screening For COVID-19

U.S. Reports 10,263 New Covid Cases, 11 Deaths

Read More

COVID-19: Drugs in Development

RELATED NEWS

Neurocrine Biosciences Inc Q2 Earnings Summary

Neurocrine Biosciences Q2 22 Earnings Conference Call At 4:30 PM ET

Neurocrine Biosciences To Particicapte In Goldman Sachs Global Healthcare Conference At 1:40 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Kraft Heinz Recalls Capri Sun Wild Cherry Flavored Beverages

Delta To Resume Flights From Los Angeles To Tokyo

Apple Sets Sept. 5 Deadline For Return To Office

Walmart Q2 Profit Up 20%; Revenues Top Estimates

Janus International Reports Profit In Q2

Over 2 Mln MamaRoo, RockaRoo Infant Swings, Rockers Recalled; Death Reported

Walmart+ Members To Get Free Paramount+ Subscription

Fifth Season Recalls Crunchy Sesame Salad Kits

Tesla Produced Over 3 Mln Vehicles, 1 Mln In China: Elon Musk

King's Hawaiian Recalls Pretzel Buns, Bites

Henkel H1 Profit Down, Backs FY22 Adj. Earnings View; Lifts Sales Forecast

Home Run Inn Recalls Frozen Meat Pizza

888 Holdings H1 Earnings Fall

Toast Up As Q2 Results Improve; Annual Sales Outlook Raised

UNITY Reports Positive Proof-of-concept Data With UBX1325 In Patients With Diabetic Macular Edema

CDC No Longer Recommends Quarantine, Screening For COVID-19

Johnson & Johnson To Discontinue Talc-based Baby Powder

Pfizer: Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine Posts Positive Results In Infants

PLx Pharma Q2 Loss Top Estimates, But Revenues Miss; Stock Down 15%

South Korea Approves Novavax's Nuvaxovid COVID-19 Vaccine For Use In Adolescents

AstraZeneca: DESTINY-Breast02 Results Confirm Efficacy Seen In Previous Trials Of ENHERTU

Walmart Q2 Profit Up 20%; Revenues Top Estimates

AstraZeneca: FDA Grants Priority Review To SNDA For Lynparza With Abiraterone For MCRPC

Aptinyx : Phase 2b Study Of NYX-2925 In Fibromyalgia Fails To Meet Main Goal

Delta To Resume Flights From Los Angeles To Tokyo

Elbit Systems Q2 Adj. Net Income Declines

Horizon Enters Option Agreement With Q32 Bio To Advance ADX-914 For Autoimmune Diseases

Humana To Acquire Substantially All Of The Assets Of Inclusa For Undisclosed Terms

Blend Labs, Inc Q2 Earnings Summary

Balfour Beatty H1 Profit, Orders Climb, Revenues Down; Sees FY22 Underlying Profit Ahead Of View

Walmart Q2 Profit Up 20%; Revenues Top Estimates

Walgreens Boots Alliance Sells 11 Mln Shares Of Option Care Health

Pfizer: Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine Posts Positive Results In Infants

Cerevel Prices Public Offering Of Common Stock, And Concurrent Private Offering Of Senior Notes

Uber Teams With Office Depot For Delivery Of Office, School Essentials

King's Hawaiian Recalls Pretzel Buns, Bites